FDA Warning Letter — Jilin Shulan Synthetic Pharmaceutical Co. Ltd.

Case 102525 — FEI 3003091092

The FDA took a Warning Letter action against Jilin Shulan Synthetic Pharmaceutical Co. Ltd. on May 13, 2010 (Jilin, China). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.

Action Details

Facility
Jilin Shulan Synthetic Pharmaceutical Co. Ltd.
Date
May 13, 2010
Fiscal Year
2010
Product Type
Drugs
Center
CDER
Location
Jilin (China)